Skip to main content
World Congress on Medical Oncology
Olympic Paris 2024
Test 4
Test 1
Test 2
Test 5
Test 3
Test clone mv
Olympic Paris 2024
Olympic Paris 2024 - VIP - Boss Ticket
Olympic Paris 2024
Finance Code Test
Concrete Institute of Australia’s Biennial National Conference 2025
Concrete Institute of Australia’s Biennial National Conference 2025
Test Goldenowl Conference
Virtual Event 01
Paris Olypmpic Clone 12.09 webinar
7th World Congress of Nanoentomology
NDS NAB Transact testing
JC test 01
Pre-Release 3 Oct
DEX (Digital Employee Experience) conference 2024
test derek
TimeZone Test
TimeZone Test
Talent Events
Event Demo
Olympic Paris 2024 x
original event name for cloning testing
Olympic Paris 2024
Default payment method test
evexus Event - 509
Default payment method test2
Test Worker
Test Worker
charlie test
Arinex 1
NET24 Ho Chi Minh City Workshop 2024
Telefilm 2024 - International Exhibition of Film and Television Technology in Vietnam
Olympic Paris 2024
charlie test 2711
charlie test 2711 cloned
CICM SecurePay testing
The AI Submit 2024
Test webinar 04.12 - - - -
Taylor Swift Clone 04
Taylor Swift Clone 02
Taylor Swift
Taylor Swift Clone
Taylor Swift Clone 01
Import Test
The Trading Summit 2024 (HCM - Vietnam)
Electric Dreams: A Synthwave Extravaganza
Taylor Swift 16
Taylor Swift 12
Taylor Swift 14
Taylor Swift 15
Taylor Swift 17
Taylor Swift 20
Coin Based Hackathon 2024
Rose 01
Import Ticket
Vu Cat Tuong
STEM 1
Kids STEM
CLONE Innovate 2025: A Future Forward Summit
Innovate 2025: A Future Forward Summit
Petals & Sunshine Festival
webinar 05/02
Science
evexus Event - 273
evexus Event - 275
Association webinar 5.2
evexus Event - 274
Aurora Nights 2025 - Webinar
Seoul AI Seminar
Webinar Event - Lily AI - 20/02
evexus Event - 287
Taylor Swift 11
Swifties Only Social Contact
cloned event for Bree QA
evexus Event - 288
evexus Event - 289
Bree QA event
Tim's event
Ralph's event
Tim cloned enable all
Ralph clone event the last one
Hawaii AI Seminar
evexus Event - 293
Tokyo Seminar
Indiana AI Seminar
Registration ticket 2025
TechNova Summit
Event - 28 - 03 - 2025
TechNova Summit [2]
TechNova Summit [3]
Tech v1
Event 28/03/2025
Job Affairs
Fan Job
Webinar Event - Lily AI - 04/03
Event Registration
Association webinar 20.2
Fan's stock query
Registration
Aurora Nights 2025
Ralph test email
Taylor Swift 13
The Core 2025
Rose
The Thirdweb submit
Stress Test Conference 2026
World Congress of Medical Oncology
Alan'event
The AI Seoul Submit 2026
The Core 2026
Times are shown in your local time zone GMT
Assessment and management of blunt cerebrovascular injuries
Verbal Presentation

Verbal Presentation

10:58 am

03 May 2026

Meeting Room M7

RESEARCH PAPERS

Talk Description

Institution: Royal Perth Hospital - WA, Australia

Purpose: Blunt cerebrovascular injury (BCVI) is a potentially devastating complication of trauma that is detected by CT angiography (CTA), guided by the Denver criteria. Acute assessment and management are well defined. Longer-term follow-up practices remain inconsistent. This study examines decade-long trends in BCVI screening, incidence, management, and follow-up at a State Trauma Unit. Methods: A retrospective cohort study was performed using the Royal Perth Hospital State Trauma Unit registry. All adults ≥18 years admitted with major trauma between 1 January 2015 and 31 December 2024 were included. Patients who had CTA for suspected BCVI were identified. Demographics, CTA indication, BCVI grade, acute management, and follow-up were extracted. Incidence was reported per major trauma admission and per CTA performed. Outcomes included hospital mortality, length of stay, and discharge destination. Analyses were descriptive and univariate, with odds ratios and confidence intervals reported. Ethics approval was obtained. Results: There were 9,724 major trauma admissions, increasing from 920 in 2015 to 1,123 in 2024. The median age was 49 years (IQR=35) with male predominance (74.7%). Use of CTA increased from 18% of admissions in 2015 to 37% in 2024. CTA was commonly indicated by radiologic findings (75.5%), with 5.0% indicated by clinical findings, and 19.5% by a combination. BCVI per CTA decreased from 20% in 2015 to 10% in 2024; BCVI per admission was static at 4.2%. BCVI associated with higher mortality (OR=2.1, 95%CI=1.6-2.8), longer length of stay by 7.5 days (95%CI=5.1-9.9), and greater need for rehabilitation (OR=2.6, 95%CI=2.1-3.3). Conclusion: BCVI incidence was consistent over a decade, despite a two-fold increase in CTA use. BCVI associated with higher mortality and morbidity, likely reflecting overall injury severity, not independent causation. Follow-up was variable, providing opportunity to standardise longer-term management pathways for BCVI patients.
Speakers
Contributors
Authors

Dr William Dunlop - , Dr Tobias Gaitt - , Dr Sana Nasim - , Dr Dieter Weber -

Other Suggested Talks
Privacy Statement Header

By confirming your acceptance below, you agree to our Privacy Policy